Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Highlights of This Issue

Highlights of this issue

CMAJ May 16, 2000 162 (10) 1397;
  • Article
  • Responses
  • Metrics
Loading

Food safety standards

In 1998 an outbreak of 39 cases of Escherichia coli O157:H7 in southern Ontario resulted in the national recall of Genoa salami. A case-control study identified that this product, produced by fermenting and drying raw meat, was the likely source (odds ratio 8, 95% confidence interval 2-35). Samples obtained from the most commonly identified supplier tested positive for E. coli O157:H7. Only two-thirds of the people infected recalled eating salami in the week preceding their illness, but 95% said that they had consumed a sliced deli product, implicating the slicer as a possible source of contamination. A similar outbreak reported in the United States in 1994 led to more stringent US production standards. According to editorialist Susan Tamblyn, meaningful changes to Canada's food safety standards were not initiated until 1999. FIGURE 1

Figure

Figure 1.

See pages 1409 and 1429

Screening for lung cancer

Lung cancer tends to be a symptom-prompted diagnosis, discovered at an advanced stage, with an overall death rate of 90%. Currently agencies in Canada and the United States recommend against screening. When baseline data from the Early Lung Cancer Action Project (ELCAP) demonstrated that CT scanning is greatly superior to traditional radiography at detecting asymptomatic lung cancer, the National Cancer Institute developed plans for a long-term randomized controlled trial (RCT) to measure the life-saving effectiveness of screening for lung cancer.

Such an RCT would be redundant according to Olli Miettinen, who illustrates that the cost-effectiveness of screening for lung cancer can already be deduced. In the ELCAP study, 23 (70%) of the 31 cases of lung cancer detected were stage IA, which has a curability rate of 70%. Miettinen therefore argues that the curability rate among cases diagnosed through screening would be about 50% (0.7 × 0.7 = 0.49). The cost (C) of one CT scan is about $200. By deducing a case-detection rate of 0.5%, a reduction in overall mortality of 40 percentage points (from 90% to 50%) and perhaps a 10-year gain in the patient's life expectancy, Miettinen calculates that the gain in life expectancy (E) from a single repeat screen would be 0.02 years (0.005 × 0.4 × 10). The cost per life-year gained (C/E) would be $10 000 ($200/0.02). We don't need an RCT to prove that suitably specified CT screening for lung cancer would be cost-effective - we already know it. Ex Canada lux? FIGURE 2

Figure

Figure 2.

See page 1431

Estrogen and surgical risk

A recent RCT identified an increased risk of gallbladder disease among postmenopausal women given estrogen replacement therapy. Estrogen may prime inflammatory and nociceptive pathways and thus increase the risk of certain surgical procedures. Using administrative data for 800 000 female residents of Ontario aged 65 years and older, Muhammad Mamdani and colleagues have compared the incidence of cholecystectomy and appendectomy among women recently prescribed estrogen replacement therapy, levothyroxine or a dihydropyridine calcium-channel antagonist (DCCA). Compared with women taking a DCCA, those taking estrogen were significantly more likely to undergo cholecystectomy (age-adjusted risk-ratio [aRR] 1.9) and appendectomy (aRR 1.8). No significant difference in either outcome measure was found between the levothyroxine users and the DCCA users.

See page 1421

Carotid angioplasty and stenting

David Pelz and Stephen Lownie review some of the evidence and the controversies surrounding carotid angioplasty and stenting. Studies of selected patients who underwent this procedure have reported technical success rates of 83% to 99% and combined stroke and death rates of 1.4% to 9%. Issues such as the use of down-stream ballooning, the need for stenting after angioplasty and the true incidence of embolic events associated with carotid angioplasty and stenting need to be resolved. Until the results of large randomized trials such as the recently funded Carotid Revascularization Endarterectomy versus Stent Trial become available, the authors advise that the procedure be reserved for patients with significant contraindications to surgery. FIGURE 3

Figure

Figure 3.

See page 1451

Footnotes

  • May 16, 2000

PreviousNext
Back to top

In this issue

CMAJ
Vol. 162, Issue 10
16 May 2000
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Highlights of this issue
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Highlights of this issue
CMAJ May 2000, 162 (10) 1397;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Highlights of this issue
CMAJ May 2000, 162 (10) 1397;
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Food safety standards
    • Screening for lung cancer
    • Estrogen and surgical risk
    • Carotid angioplasty and stenting
    • Footnotes
  • Responses
  • Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Highlights
  • Highlights
  • Highlights of this issue
Show more Highlights of this Issue

Similar Articles

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

CMA Civility, Accessibility, Privacy

 

Powered by HighWire